NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









CeQur

CeQur

Private
HorwHealthcare & Life Scienceshttps://myceqursimplicity.com/

Last Round

Series E

Jun 9, 2026

Total Funding Raised

$514M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

CeQur is a medical device company that develops and commercializes wearable insulin delivery patches designed to simplify mealtime insulin administration for patients with diabetes.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT

Business Model

B2B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

insulin delivery devicewearable insulin patchinsulin pumpdiabetes managementbolus insulinmealtime insulintype 2 diabetesmedical devicepharmacy benefitpatch pumpinsulin deliverydiscreet insulinPBMpharmacy benefit manager

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CeQur Comparables

Compare CeQur with similar companies based on industry and business-model similarity.

CeQur comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MannKind Corp
78%
PharmaSens AG
75%
Tandem Diabetes Care, Inc.
75%

CeQur Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series EJun 9, 2026
Series DJan 7, 2025
Series C ExtensionApr 13, 2021
Series CSep 1, 2015
Series BSep 9, 2013
Series A
Jan 5, 2010

Key People

Founding team and executive leadership

Bradley Paddock

President CEO

Executive Team

Michael Rubino

Chief Financial Officer

Executive Team

CeQur Investors

Notable investors and investment history

CeQur investors
InvestorRounds
GMS CapitalSeries C Extension
VI PartnersSeries C Extension, Series D, Series C, Series A, Series B
Schroder Investment Management LimitedSeries A
Woodford Investment ManagementSeries C
Endeavour VisionSeries D, Series B, Series C, Series A, Series C Extension
GMS Capital PartnersSeries C Extension
Schroder & Co. BankSeries C Extension, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 9, 2026

    $100M round raised.

  • Jan 7, 2025

    $120M raised in early funding.

CeQur Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CeQur Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CeQur's valuation, stock price, and market status.

Firmographic Details

HeadquartersHorw
Employee Range140
Year Founded2008
Last FundingJun 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.